Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey

Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis

(2013) Katrina E. Donahue et al.   ANNALS OF INTERNAL MEDICINE

Receipt of Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis in Medicare Managed Care Plans

(2011) Gabriela Schmajuk et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis

(2010) C. Salliot et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Quality care in seniors with new-onset rheumatoid arthritis: A Canadian perspective

(2010) Jessica Widdifield et al.   ARTHRITIS CARE & RESEARCH

Physician Performance and Racial Disparities in Diabetes Mellitus Care

(2008) Thomas D. Sequist   ARCHIVES OF INTERNAL MEDICINE

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

(2008) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM